Researchers develop 3D bioprinting technology for eliminating cancer cells

FHS
July 12, 2023
3:19 am

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.

The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S.

December 20, 2024

Dementia Mortality Tied to Olive Oil Consumption

Higher olive oil intake was associated with a lower risk of dementia-related death in a large longitudinal study. The relationship remained significant after adjusting for

May 7, 2024

33% of Patients Delay Diagnostic Tests, 78% Fear Blood Drawn

What You Should Know: – A recent survey by Tasso, Inc., a provider of patient-centric blood collection solutions reveals 33% of patients delay or avoid

October 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.